Anecdotal evidence that ongoing direct oral anticoagulant (DOAC) use might reduce a patient’s risk for severe disease with COVID-19 appears to have been wishful thinking, if the results of a study just published in the Journal of Internal Medicine are any indication. The authors found no association between DOAC use and lower incidence of hospital admission for COVID-19, or a composite of intensive care unit admission of death. As such, they concluded that DOAC use …
Read More![Update: Study Finds No Evidence That DOAC Use Reduces Risk for Severe COVID-19 Update: Study Finds No Evidence That DOAC Use Reduces Risk for Severe COVID-19](https://www.jucm.com/wp-content/uploads/2020/12/Study-Finds-Not-Evidence-image-380x253-1-750x350.jpeg)